• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清糖蛋白在大肠癌患者诊断和监测中的应用

Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer.

作者信息

Walker C, Gray B N, Barnard R

出版信息

Dis Colon Rectum. 1981 Apr;24(3):171-5. doi: 10.1007/BF02962327.

DOI:10.1007/BF02962327
PMID:7227130
Abstract

The profile of serum glycoproteins is altered in malignancy with a relative increase in acute phase reactant proteins. A prospective study has been performed to investigate three sugar moieties (hexose, hexosamine and sialic acid) of these glycoproteins in the serum of large-bowel cancer patients as a possible guide to recurrence, and to compare these three variables with carcinoembryonic antigen (CEA). The three variables indicated the presence of colorectal cancer in over 65 per cent of 107 cancer-bearing subjects. Furthermore, the appearance of metastatic disease was associated with abnormalities in these variables in 10 of 11 patients, and appears more accurately reflected than with CEA. However, the three variables and CEA are cumulative in their value for predicting recurrent cancer. Monitoring of acute phase reactant proteins may therefore be of potential clinical benefit for monitoring of colorectal cancer patients at high risk of recurrence.

摘要

恶性肿瘤患者血清糖蛋白谱会发生改变,急性期反应蛋白相对增加。已开展一项前瞻性研究,以调查大肠癌患者血清中这些糖蛋白的三种糖基(己糖、己糖胺和唾液酸),作为复发的可能指标,并将这三个变量与癌胚抗原(CEA)进行比较。这三个变量在107名癌症患者中超过65%的病例中提示存在结直肠癌。此外,11名患者中有10名出现转移疾病与这些变量异常有关,且比CEA更能准确反映。然而,这三个变量和CEA在预测复发性癌症方面具有累积价值。因此,监测急性期反应蛋白可能对监测具有高复发风险的结直肠癌患者具有潜在的临床益处。

相似文献

1
Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer.血清糖蛋白在大肠癌患者诊断和监测中的应用
Dis Colon Rectum. 1981 Apr;24(3):171-5. doi: 10.1007/BF02962327.
2
Acute-phase reactant proteins and carcinoembryonic antigen in cancer of the colon and rectum.结直肠癌中的急性期反应蛋白和癌胚抗原
Cancer. 1983 Jul 1;52(1):150-4. doi: 10.1002/1097-0142(19830701)52:1<150::aid-cncr2820520127>3.0.co;2-0.
3
[Carcinoembryonic antigen (CEA) in surgically treated cancer of the large intestine].[手术治疗的大肠癌中的癌胚抗原(CEA)]
Schweiz Med Wochenschr. 1983 Apr 16;113(15):548-9.
4
Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.癌胚抗原(CEA)在结直肠癌诊断及预后中的作用
Dis Colon Rectum. 1980 Apr;23(3):141-4. doi: 10.1007/BF02587615.
5
[Value of radioimmunological serum levels of carcinoembryonic antigen in the postoperative monitoring of rectocolonic cancer].[癌胚抗原放射免疫血清水平在结直肠癌术后监测中的价值]
Ann Gastroenterol Hepatol (Paris). 1984 Jul-Sep;20(4):203-6.
6
Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.癌胚抗原斜率分析作为结直肠癌复发的早期指标
Jpn J Surg. 1986 Mar;16(2):106-11. doi: 10.1007/BF02471079.
7
A critical comparison of the value of pregnancy-associated alpha2-glycoprotein and carcinoembryonic antigen assays in patients with colorectal cancer.结直肠癌患者中妊娠相关α2-糖蛋白和癌胚抗原检测价值的关键比较。
J Clin Pathol. 1978 Nov;31(11):1065-7. doi: 10.1136/jcp.31.11.1065.
8
[The use of CEA radioimmunoassay for the detection of recurrence of carcinoma of the large bowel (author's transl)].癌胚抗原放射免疫测定法用于检测大肠癌复发(作者译)
Langenbecks Arch Chir. 1976 Nov 15;342:243-9. doi: 10.1007/BF01267376.
9
Serum carcinoembryonic antigen and acute phase reactant proteins in the pre-operative detection of fixation of colorectal tumours.血清癌胚抗原和急性期反应蛋白在结直肠肿瘤固定术前检测中的应用
Br J Surg. 1984 Nov;71(11):881-4. doi: 10.1002/bjs.1800711126.
10
Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.血清CA 242和癌胚抗原可检测出不同的复发性结直肠癌患者。
Anticancer Res. 1996 Mar-Apr;16(2):981-6.